financetom
Market
financetom
/
Market
/
CME profit tops estimates, CEO says 'perps' chatter overshadows results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CME profit tops estimates, CEO says 'perps' chatter overshadows results
Jul 22, 2026 12:26 PM

July 22 (Reuters) - CME Group ( CME ) beat Wall Street's second-quarter profit estimates on Wednesday, fueled by strong hedging demand, sending the derivatives exchange's shares up 6.1%.

Meanwhile, the company's outgoing CEO, Terry Duffy, reiterated his criticism of perpetual futures, which are listed derivatives without an expiration date. These contracts allow traders to maintain positions indefinitely without the need to roll them ​over.

"Strong business performance has been overshadowed by discussions surrounding perpetual futures," Duffy said in a post-earnings call with analysts.

The company's second-quarter adjusted profit of $2.99 per share beat analysts' estimates of $2.91 per share, according to data compiled by LSEG.

It was also higher than the $2.96 per share it recorded for the same period last year, when U.S. President Donald Trump announced his Liberation Day tariffs, helping the derivatives exchange post record average daily volumes, or ADV.

In the current quarter, developments around the U.S.-Israeli war with Iran and the wider Middle East conflict kept markets volatile, which helped the exchange, but to a lesser extent.

The company's total ADV was down 1% from last year, largely as volumes in interest rate and energy contracts were down and that for metals trading was flat.

However, its ADV for equity indexes jumped 13% during the quarter, as investors showed interest in these products due to a 14.9% rise in the benchmark S&P 500 index.

Agricultural and cryptocurrency ADV also rose in the second quarter.

Revenue in its market data and information services segment increased 20.2%, while its clearing and transaction fees fell 2.6%.

"Overall we view this as a solid quarter for CME on the back of tough 1Q26 & 2Q25 comparisons," Piper Sandler analysts said in a note.

CME CUSTOMERS HAVE NOT SOUGHT PERPETUAL FUTURES

Despite the strong earnings, the company's stock is down 8% so far this year, partly as investors worry that the so-called "perps" - which secured regulatory approval on May 29 - would eat into traditional exchange operators' market share.

Duffy said the exchange has full technical and operational capabilities to launch perps, but has not seen any demand from its customers for the product.

"These products do not appeal to our core customers."

The stock has underperformed most of its major peers except New York Stock Exchange-parent Intercontinental Exchange as of last close.

"We believe the bear case related to perpetual futures will prove to be a non-event for CME, but in the meantime it has created an attractive entry point for CME's shares," said analysts at Raymond James in a note.

Duffy, who took over ⁠the ​role of CEO about a decade ago at the derivatives exchange, will make ​way for insider Lynne Fitzpatrick, who will take over as CME's first female CEO on March 1 next year, the company announced in June.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Earnings in Focus as US Equity Futures Post Narrow Gains Pre-Bell
Nvidia Earnings in Focus as US Equity Futures Post Narrow Gains Pre-Bell
Nov 21, 2024
08:50 AM EST, 11/21/2024 (MT Newswires) -- US equity futures were cautiously higher ahead of Thursday's opening bell as traders digested earnings and guidance from artificial intelligence chipmaker Nvidia ( NVDA ) . Dow Jones Industrial Average futures rose 0.4%, S&P 500 futures gained 0.4%, and Nasdaq futures were up 0.3%. Nvidia ( NVDA ) reported late Wednesday fiscal Q3...
Sector Update: Health Care
Sector Update: Health Care
Nov 21, 2024
08:52 AM EST, 11/21/2024 (MT Newswires) -- Health care stocks rose in pre-bell hours Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) up 0.3% recently. Zymeworks ( ZYME ) and Jazz Pharmaceuticals ( JAZZ ) said they have received accelerated approval for Ziihera from the US Food and Drug Administration...
US STOCKS-Wall St set for higher open after jobless claims data, Nvidia results
US STOCKS-Wall St set for higher open after jobless claims data, Nvidia results
Nov 21, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Snowflake jumps after raising annual product revenue forecast * Deere shares up after Q4 profit beats estimates * Crypto stocks gain as bitcoin prices near $100,000 * Weekly jobless claims stand at 213,000 * Futures: Dow up 0.45%, S&P...
Sector Update: Tech
Sector Update: Tech
Nov 21, 2024
08:45 AM EST, 11/21/2024 (MT Newswires) -- Technology stocks were edging higher premarket Thursday as the Technology Select Sector SPDR Fund (XLK) was up 0.7% and the SPDR S&P Semiconductor ETF (XSD) marginally advanced. Snowflake (SNOW) shares rose past 24% after the company reported fiscal Q3 earnings and sales above analyst expectations. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved